-
DSP Healthcare Fund Regular Growth
Equity healthcare
Overview ( as on 17/01/25 )
NAV
₹40.62
Last change
₹-0.01 -0.0%
Fund Size (AUM)
3339.79 Cr
Performance
28.66% (5Y)
Fund Details
DSP Healthcare Fund Regular Growth
as of 17/01/25
AUM
3339.79 Cr
Expense Ratio
1.9 %
Benchmark
BSE Healthcare TR INR
ISIN
INF740KA1LD8
Fund Manager
Chirag Dagli
Exit Load
0.5% if redeemed within 0-1 months
0% if redeemed after 1 months
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| DSP Healthcare Fund Regular Growth | 34.18% | 20.89% | 28.66% |
| BSE Healthcare TR INR | 43.51% | 19.99% | 27.52% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
10.59% |
Suven Pharmaceuticals Ltd |
8.49% |
Cipla Ltd |
8.2% |
Ipca Laboratories Ltd |
8.14% |
Alembic Pharmaceuticals Ltd |
4.54% |
Gland Pharma Ltd |
4.38% |
Apollo Hospitals Enterprise Ltd |
4.07% |
Concord Biotech Ltd |
3.87% |
Sai Life Sciences Ltd |
3.55% |
Laurus Labs Ltd |
3.5% |
Sector Allocation
Healthcare |
98.67% |
Financial |
1.33% |
Asset Allocation
-
97%
Equity
-
3%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
ICICI Pru Pharma Healthcare Diag Gr
Equity healthcare-
Returns
-
28.64% (5Y)
-
-
ICICI Pru Pharma Healthcare Dg IDCW-R
Equity healthcare-
Returns
-
25.81% (5Y)
-
-
SBI Healthcare Opportunities Reg Gr
Equity healthcare-
Returns
-
27.8% (5Y)
-
-
SBI Healthcare Opportunities Reg IDCW-R
Equity healthcare-
Returns
-
27.8% (5Y)
-
-
DSP Healthcare Fund Reg Gr
Equity healthcare-
Returns
-
28.66% (5Y)
-
-
Tata India Pharma & Healthcare RegIDCW-R
Equity healthcare-
Returns
-
25.59% (5Y)
-
